RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 41 filers reported holding RAIN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $211 | -96.6% | 245 | -95.2% | 0.00% | – |
| Q2 2023 | $6,133 | -98.3% | 5,111 | -87.5% | 0.00% | – |
| Q1 2023 | $356,085 | +65.1% | 40,742 | +51.1% | 0.00% | – |
| Q4 2022 | $215,664 | +21466.4% | 26,958 | +11934.8% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 224 | -49.0% | 0.00% | – |
| Q2 2022 | $2,000 | -66.7% | 439 | -65.6% | 0.00% | – |
| Q1 2022 | $6,000 | -91.7% | 1,277 | -77.1% | 0.00% | – |
| Q4 2021 | $72,000 | +453.8% | 5,572 | +539.7% | 0.00% | – |
| Q3 2021 | $13,000 | +30.0% | 871 | +32.0% | 0.00% | – |
| Q2 2021 | $10,000 | – | 660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,571,379 | $7,967,000 | 2.01% |
| Cormorant Asset Management, LP | 2,326,660 | $11,796,000 | 0.91% |
| BVF INC/IL | 3,526,729 | $17,881,000 | 0.72% |
| Boxer Capital, LLC | 1,175,000 | $5,957,000 | 0.31% |
| Perceptive Advisors | 2,483,619 | $12,592,000 | 0.25% |
| Logos Global Management LP | 134,194 | $680,000 | 0.09% |
| Lumina Fund Management LLC | 6,000 | $30,000 | 0.01% |
| Woodline Partners LP | 119,700 | $607,000 | 0.01% |
| Trexquant Investment LP | 28,373 | $144,000 | 0.01% |
| Alyeska Investment Group, L.P. | 125,000 | $634,000 | 0.01% |